Literature DB >> 20617462

Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.

Patrick Vandeputte1, Laurent Pineau, Gérald Larcher, Thierry Noel, Daniel Brèthes, Dominique Chabasse, Jean-Philippe Bouchara.   

Abstract

Resistance to 5-fluorocytosine (5-FC) has been poorly investigated in the yeast Candida glabrata. This study was conducted on laboratory mutants obtained by exposure of a wild-type isolate to 5-FC. Based on their susceptibility to 5-fluorouracil (5-FU), two of these mutants were selected for further analysis of the molecular mechanisms of 5-FC resistance. One mutant, resistant to both compounds, exhibited a missense mutation in the gene coding the cytosine deaminase and a decrease in the expression level of the gene coding the uridine monophosphate pyrophosphorylase. The other mutant that showed a reduced susceptibility to 5-FC and 5-FU exhibited an overexpression of the genes coding the thymidylate synthase and a cytosine permease, associated with a missense mutation in the last gene. Thus, beside mutations in the FUR1 gene which represent the most common cause of resistance to 5-FC, other mechanisms may also occur in C. glabrata.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617462     DOI: 10.1007/s11046-010-9342-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  34 in total

1.  Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans.

Authors:  M O Fasoli; D Kerridge
Journal:  J Gen Microbiol       Date:  1990-08

2.  Isolation and characterization of fluoropyrimidine-resistant mutants in two Candida species.

Authors:  M Fasoli; D Kerridge
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

Authors:  Florence Chapeland-Leclerc; Julien Bouchoux; Abdelhak Goumar; Christiane Chastin; Jean Villard; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  5-Fluorocytosine--current status with special references to mode of action and drug resistance.

Authors:  A Polak
Journal:  Contrib Microbiol Immunol       Date:  1977

5.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; M G Rinaldi; R Barnes; B Hu; A V Veselov; N Tiraboschi; E Nagy; D L Gibbs
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 6.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

Review 7.  Risk of resistance associated with fluconazole prophylaxis: systematic review.

Authors:  Luc P Brion; Smart E Uko; David L Goldman
Journal:  J Infect       Date:  2007-01-18       Impact factor: 6.072

8.  Photoaffinity labeling and characterization of the cloned purine-cytosine transport system in Saccharomyces cerevisiae.

Authors:  R Schmidt; M F Manolson; M R Chevallier
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

Review 9.  Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.

Authors:  P Francis; T J Walsh
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

10.  Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution.

Authors:  Tzu-Ping Ko; Jing-Jer Lin; Chih-Yung Hu; Yi-Hsin Hsu; Andrew H-J Wang; Shwu-Huey Liaw
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

View more
  15 in total

Review 1.  Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

2.  Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.

Authors:  M A Pfaller; A Espinel-Ingroff; E Canton; M Castanheira; M Cuenca-Estrella; D J Diekema; A Fothergill; J Fuller; M Ghannoum; R N Jones; S R Lockhart; E Martin-Mazuelos; M S C Melhem; L Ostrosky-Zeichner; P Pappas; T Pelaez; J Peman; J Rex; M W Szeszs
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

3.  Mutational analysis of flucytosine resistance in Candida glabrata.

Authors:  Thomas D Edlind; Santosh K Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

4.  Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections.

Authors:  Mario D Garcia; Sheena M H Chua; Yu-Shang Low; Yu-Ting Lee; Kylie Agnew-Francis; Jian-Guo Wang; Amanda Nouwens; Thierry Lonhienne; Craig M Williams; James A Fraser; Luke W Guddat
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-24       Impact factor: 11.205

5.  Dysfunction of Prohibitin 2 Results in Reduced Susceptibility to Multiple Antifungal Drugs via Activation of the Oxidative Stress-Responsive Transcription Factor Pap1 in Fission Yeast.

Authors:  Qiannan Liu; Fan Yao; Guanglie Jiang; Min Xu; Si Chen; Lina Zhou; Norihiro Sakamoto; Takayoshi Kuno; Yue Fang
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

6.  Antifungal resistance and new strategies to control fungal infections.

Authors:  Patrick Vandeputte; Selene Ferrari; Alix T Coste
Journal:  Int J Microbiol       Date:  2011-12-01

Review 7.  What 'Omics can tell us about antifungal adaptation.

Authors:  Gabriela Fior Ribeiro; Eszter Denes; Helen Heaney; Delma S Childers
Journal:  FEMS Yeast Res       Date:  2022-01-11       Impact factor: 2.923

Review 8.  Emerging Threats in Antifungal-Resistant Fungal Pathogens.

Authors:  Dominique Sanglard
Journal:  Front Med (Lausanne)       Date:  2016-03-15

Review 9.  Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.

Authors:  Claudia Spampinato; Darío Leonardi
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

Review 10.  Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.

Authors:  Daniel Michał Kamiński
Journal:  Eur Biophys J       Date:  2014-08-31       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.